GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:10087069
| Citation |
Cooper, JD, Messer, A, Feng, AK, Chua-Couzens, J and Mobley, WC (1999) Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J. Neurosci. 19:2556-67 |
|---|---|
| Abstract |
The neuronal ceroid lipofuscinoses (NCL) are progressive neurodegenerative disorders with onset from infancy to adulthood that are manifested by blindness, seizures, and dementia. In NCL, lysosomes accumulate autofluorescent proteolipid in the brain and other tissues. The mnd/mnd mutant mouse was first characterized as exhibiting adult-onset upper and lower motor neuron degeneration, but closer examination revealed early, widespread pathology similar to that seen in NCL. We used the autofluorescent properties of accumulated storage material to map which CNS neuronal populations in the mnd/mnd mouse show NCL-like pathological changes. Pronounced, early accumulation of autofluorescent lipopigment was found in subpopulations of GABAergic neurons, including interneurons in the cortex and hippocampus. Staining for phenotypic markers normally present in these neurons revealed progressive loss of staining in the cortex and hippocampus of mnd/mnd mice, with pronounced hypertrophy of remaining detectable interneurons. In contrast, even in aged mutant mice, many hippocampal interneurons retained staining for glutamic acid decarboxylase. Treatment with insulin-like growth factor-1 partially restored interneuronal number and reduced hypertrophy in some subregions. These results provide the first evidence for the involvement of interneurons in a mouse model of NCL. Moreover, our findings suggest that at least some populations of these neurons persist in a growth factor-responsive state. |
| Links | |
| Keywords |
Aging/pathology; Animals; Atrophy; Cerebral Cortex/pathology; Cerebral Ventricles; Fluorescence; Hypertrophy/drug therapy; Hypertrophy/pathology; Infusions, Parenteral; Insulin-Like Growth Factor I/therapeutic use; Interneurons/physiology; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuronal Ceroid-Lipofuscinoses/drug therapy; Neuronal Ceroid-Lipofuscinoses/pathology; Parvalbumins/analysis; Phenotype |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
See also
References
See Help:References for how to manage references in GONUTS.
